Carlo Mordasini

Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial

Rolf A. Stahel, Oliver Riesterer, Alexandros Xyrafas et al. · The Lancet Oncology · 2015 · 201 citations

Medicine, Oncology, Surgery +15

Molecular approach to identifying route of transmission of tuberculosis in the community

A. Genewein, Amalio Telenti, C. Bernasconi et al. · The Lancet · 1993 · 192 citations

Public Health, Infectious Diseases, Microbiology +12

Tracking a Tuberculosis Outbreak Over 21 Years: Strain-Specific Single-Nucleotide Polymorphism Typing Combined With Targeted Whole-Genome Sequencing

David Stucki, Marie Ballif, Thomas Bodmer et al. · The Journal of Infectious Diseases · 2014 · 90 citations · Full text

Public Health, Genetics, Molecular Genetics +17

Long-Term Follow-Up and Survival after UltraflexTM Stent Insertion in the Management of Complex Malignant Airway Stenoses

A. Breitenbücher, Prashant N. Chhajed, Martin Brutsche et al. · Respiration · 2008 · 77 citations · Full text

Medicine, Surgery, Metastasis +12

Neoadjuvant Chemotherapy and Extrapleural Pneumonectomy (Epp) of Malignant Pleural Mesothelioma (Mpm) with or Without Hemithoracic Radiotherapy: Final Results of the Randomized Multicenter Phase Ii Trial Sakk17/04

R. Stahel, Oliver Riesterer, X. Alexandros et al. · Annals of Oncology · 2014 · 10 citations · Full text

Medicine, Oncology, Surgery +15